Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival.

Impact of body mass index on ovarian cancer survival varies by stage. Br J Cancer (2017) 0.76

Racial health disparities in ovarian cancer: not just black and white. J Ovarian Res (2017) 0.75

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54

Building a virtual cancer research organization. J Natl Cancer Inst Monogr (2005) 3.60

The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS (Wash DC) (2014) 2.83

The calculation of received dose intensity. J Clin Oncol (1990) 2.76

Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol (2009) 2.61

Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin (2011) 2.57

Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol (2006) 2.17

Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat (2003) 2.14

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin (2015) 1.70

Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst (2003) 1.68

Global ovarian cancer health disparities. Gynecol Oncol (2012) 1.24

Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer. Gynecol Oncol (2012) 1.04

Race in ovarian cancer treatment and survival: a systematic review with meta-analysis. Cancer Causes Control (2009) 1.03

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol (2012) 0.94

Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective. Adv Nutr (2015) 0.93

Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS). Gynecol Oncol (2014) 0.90

CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol (2014) 0.87

Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. Gynecol Oncol (2014) 0.86

Characterization of the Hispanic or latino population in health research: a systematic review. J Immigr Minor Health (2014) 0.86

Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index. JAMA Oncol (2015) 0.83

Outcomes in Ovarian Cancer among Hispanic Women Living in the United States: A Population-Based Analysis. Patholog Res Int (2013) 0.79

Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev (2014) 0.81

The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology. Cancer Epidemiol Biomarkers Prev (2015) 0.79

Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res (2016) 0.77

Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev (2017) 0.75

Body mass index, PAM50 subtype, recurrence and survival among patients with nonmetastatic breast cancer. Cancer (2017) 0.75

Impact of the Affordable Care Act on Colorectal Cancer Incidence and Mortality. Am J Prev Med (2021) 0.75

Peripubertal dietary flavonol and lignan intake and age at menarche in a longitudinal cohort of girls. Pediatr Res (2017) 0.75

Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev (2017) 0.75

Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer (2017) 0.75

Vitamin D and Breast Cancer Survival-In Reply. JAMA Oncol (2017) 0.75